| scholarly article | Q13442814 |
| P50 | author | Josef Penninger | Q1674391 |
| Ricardo Pena Silva | Q43122518 | ||
| Frank M Faraci | Q86046795 | ||
| P2093 | author name string | Yi Chu | |
| Jordan D Miller | |||
| Donald D Heistad | |||
| Ian J Mitchell | |||
| P2860 | cites work | Disruption of the Ang II type 1 receptor promotes longevity in mice | Q24647615 |
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors | Q28218830 | ||
| Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals | Q28511880 | ||
| Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress | Q28584121 | ||
| Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
| Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals | Q33232591 | ||
| Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. | Q33265176 | ||
| Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain | Q33281864 | ||
| Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease | Q33387233 | ||
| Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus | Q33652507 | ||
| The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension | Q33726694 | ||
| Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation | Q33835991 | ||
| Severe acute respiratory syndrome, Beijing, 2003 | Q34973792 | ||
| Protecting against vascular disease in brain | Q34979773 | ||
| Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. | Q35142935 | ||
| Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction | Q35587023 | ||
| Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease | Q36343094 | ||
| Neurovascular unit dysfunction: a vascular component of Alzheimer disease? | Q36821841 | ||
| Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis | Q37101896 | ||
| Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages | Q37122931 | ||
| Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging | Q37276197 | ||
| Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria? | Q37785713 | ||
| Regulator of calcineurin 1 mediates pathological vascular wall remodeling | Q38583217 | ||
| Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke | Q40551007 | ||
| Evidence that prolyl endopeptidase participates in the processing of brain angiotensin | Q41974935 | ||
| Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. | Q42521222 | ||
| Relationship of angiotensin-converting enzyme 2 gene polymorphism with the prognosis of hypertensive stroke patients | Q43179505 | ||
| Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events | Q44456357 | ||
| Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. | Q45959996 | ||
| ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects | Q46273463 | ||
| Regulation of vascular function by RCAN1 (ADAPT78). | Q46738087 | ||
| Age- and gender-related difference of ACE2 expression in rat lung | Q47686945 | ||
| In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats | Q48478548 | ||
| No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. | Q51995128 | ||
| Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. | Q53463683 | ||
| Endothelial Function in Resistance and Conduit Arteries and 5-Year Risk of Cardiovascular Disease | Q61442738 | ||
| Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery | Q74071611 | ||
| Ageing alters aortic antioxidant enzyme activities in Fischer-344 rats | Q78195923 | ||
| Modulation of dilator responses of cerebral arterioles by extracellular superoxide dismutase | Q79157022 | ||
| Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women | Q80251093 | ||
| Cerebral vascular dysfunction during hypercholesterolemia | Q80382250 | ||
| Advanced age is associated with endothelial dysfunction in healthy elderly subjects | Q81164809 | ||
| SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans | Q84539908 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3358-3363 | |
| P577 | publication date | 2012-11-15 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging | |
| P478 | volume | 43 |
| Q94947170 | ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome |
| Q48176579 | ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway |
| Q34158064 | Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction |
| Q36825182 | Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence |
| Q94553710 | Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad? |
| Q50069551 | Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor |
| Q94571148 | COVID-19, Angiotensin Receptor Blockers, and the Brain |
| Q26751153 | Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy? |
| Q34117919 | Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. |
| Q92097301 | Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice |
| Q95835148 | Does SARS-CoV-2 infection cause chronic neurological complications? |
| Q99708624 | Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy |
| Q59810561 | Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney |
| Q35986974 | Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress |
| Q54192569 | Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease. |
| Q35275410 | Impaired dynamic cerebral autoregulation at rest and during isometric exercise in type 2 diabetes patients. |
| Q37411080 | Interleukin-10 protects against aging-induced endothelial dysfunction. |
| Q39169210 | Microvascular NADPH oxidase in health and disease. |
| Q42115455 | Promising neuroprotective effects of the angiotensin-(1-7)-angiotensin-converting enzyme 2-Mas axis in stroke |
| Q42376408 | Regulation of exercise blood flow: Role of free radicals |
| Q90011350 | Role of brain renin angiotensin system in neurodegeneration: An update |
| Q41826458 | Stages in Discovery: Angiotensin-Converting Enzyme Type 2 and Stroke. |
| Q47851502 | The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). |
| Q27308039 | Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes. |
| Q35960738 | Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study |
Search more.